USANA Health Sciences (NYSE:USNA) Insider David Mulham Mulham Sells 873 Shares

USANA Health Sciences, Inc. (NYSE:USNA) insider David Mulham Mulham sold 873 shares of the stock in a transaction that occurred on Wednesday, December 10th. The shares were sold at an average price of $21.00, for a total value of $18,333.00. Following the transaction, the insider owned 8,387 shares of the company’s stock, valued at approximately $176,127. This trade represents a 9.43% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink.

USANA Health Sciences Price Performance

Shares of NYSE:USNA traded down $0.08 during midday trading on Friday, reaching $20.79. The company had a trading volume of 1,060 shares, compared to its average volume of 192,989. The stock has a market capitalization of $380.04 million, a P/E ratio of 23.63, a PEG ratio of 1.01 and a beta of 0.66. The stock’s fifty day moving average price is $20.66 and its 200-day moving average price is $27.13. USANA Health Sciences, Inc. has a one year low of $18.48 and a one year high of $38.32.

USANA Health Sciences (NYSE:USNA) last posted its quarterly earnings data on Thursday, October 9th. The company reported $0.56 EPS for the quarter. The firm had revenue of $200.22 million for the quarter. USANA Health Sciences had a net margin of 1.86% and a return on equity of 6.97%. USANA Health Sciences has set its Q3 2025 guidance at -0.150–0.150 EPS. As a group, sell-side analysts forecast that USANA Health Sciences, Inc. will post 2.45 earnings per share for the current year.

Analyst Upgrades and Downgrades

Several analysts recently weighed in on USNA shares. Zacks Research raised USANA Health Sciences from a “strong sell” rating to a “hold” rating in a report on Tuesday. Wall Street Zen lowered USANA Health Sciences from a “buy” rating to a “hold” rating in a research report on Saturday, October 11th. Finally, Weiss Ratings reaffirmed a “sell (d+)” rating on shares of USANA Health Sciences in a report on Monday. Three equities research analysts have rated the stock with a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of “Reduce” and an average price target of $36.00.

Hedge Funds Weigh In On USANA Health Sciences

Institutional investors have recently made changes to their positions in the stock. Pzena Investment Management LLC lifted its holdings in shares of USANA Health Sciences by 1.2% in the 3rd quarter. Pzena Investment Management LLC now owns 1,212,588 shares of the company’s stock worth $33,407,000 after purchasing an additional 14,328 shares during the last quarter. Vanguard Group Inc. increased its position in USANA Health Sciences by 5.7% in the third quarter. Vanguard Group Inc. now owns 1,069,032 shares of the company’s stock worth $29,452,000 after buying an additional 57,249 shares during the period. Dimensional Fund Advisors LP lifted its stake in USANA Health Sciences by 1.9% in the third quarter. Dimensional Fund Advisors LP now owns 915,049 shares of the company’s stock valued at $25,210,000 after buying an additional 17,318 shares during the last quarter. American Century Companies Inc. boosted its holdings in shares of USANA Health Sciences by 9.2% during the first quarter. American Century Companies Inc. now owns 255,242 shares of the company’s stock valued at $6,884,000 after acquiring an additional 21,445 shares during the period. Finally, Jacobs Levy Equity Management Inc. boosted its holdings in shares of USANA Health Sciences by 46.2% during the first quarter. Jacobs Levy Equity Management Inc. now owns 188,511 shares of the company’s stock valued at $5,084,000 after acquiring an additional 59,535 shares during the period. 54.25% of the stock is owned by institutional investors.

USANA Health Sciences Company Profile

USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.